Protalix BioTherapeutics (PLX) Misses Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.29 +3.15%
Financial Fact:
NET LOSS FOR THE PERIOD: -7.29M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
NET LOSS FOR THE PERIOD: -7.29M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported Q2 EPS of ($0.03). Revenue for the quarter came in at $13.47 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Datavault AI to acquire CyberCatch for $94.5M in all-cash deal
- CalPrivate Bank names Andra Frazier as chief credit officer
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
